Alnylam Pharmaceuticals, Inc. (ALNY) Social Stream
Alnylam Pharmaceuticals Inc (ALNY) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ALNY.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-19 | 17 | $275 | $108 | $200 | $162.43 | 23.13% |
| 2021-11-22 | 18 | $275 | $108 | $200 | $162.43 | 23.13% |
| 2021-12-29 | 19 | $275 | $108 | $202.5 | $162.43 | 24.67% |
| 2022-01-11 | 19 | $275 | $108 | $203.85 | $162.43 | 25.5% |
| 2022-01-18 | 19 | $275 | $108 | $203.3 | $162.43 | 25.16% |
| 2022-01-23 | 19 | $350 | $108 | $208.3 | $162.43 | 28.24% |
| 2022-01-28 | 18 | $350 | $108 | $208.2 | $162.43 | 28.18% |
| 2022-02-10 | 18 | $350 | $109 | $208.65 | $162.43 | 28.46% |
| 2022-02-14 | 16 | $350 | $103 | $212.052 | $162.43 | 30.55% |
| 2022-02-22 | 16 | $350 | $103 | $214.166 | $162.43 | 31.85% |
| 2022-03-10 | 16 | $350 | $103 | $214.631 | $162.43 | 32.14% |
The Trend in the Analyst Price Target
Over the past 39 weeks, ALNY's average price target has gone up $39.85.
ALNY reports an average of 18.84% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-04-25 | 22 | 235 | 90 | 175.11 | 136.72 | 28.08% |
| 2021-07-17 | 22 | 235 | 91 | 175.83 | 177.54 | -0.96% |
| 2021-08-05 | 22 | 235 | 93 | 180.68 | 193.90 | -6.82% |
| 2021-09-04 | 22 | 250 | 93 | 183.79 | 197.46 | -6.92% |
| 2021-12-29 | 19 | 275 | 108 | 202.50 | 170.08 | 19.06% |
ALNY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.41 | 11 | 3 | 2 | 0 | 0 | 16 |
The Trend in the Broker Recommendations
ALNY's average broker recommendation rating improved by 0.88 over the prior 30 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ALNY as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Alnylam Pharmaceuticals Inc's variance in analysts' estimates is lower than -1378.95% of them.
- Alnylam Pharmaceuticals Inc's number of analysts covering the stock is higher than 1534.1% of Pharmaceutical Products stocks.
- In terms of how Alnylam Pharmaceuticals Inc fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 1507.76% of that group.
- ALNY has a greater upside potential (average analyst target price relative to current price) than 203.1% of Pharmaceutical Products stocks.
Stocks similar to Alnylam Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ALKS, ABCL, and VIR.
Is ALNY a Buy, Hold or Sell? See the POWR Ratings now!